Contact us today for a complimentary consultation with a qualified attorney near you.
–May 13, 2004
U.S. criminal charges were brought against Pfizer Inc.'s Warner-Lambert unit for misbranding the epilepsy drug Neurontin. The company has agreed to plead guilty and pay more than $430 million to settle the charges of promoting the drug for off-label purposes.
For more information on Neurontin, please contact us.